MCV4, Menveo-one® (CDC) Federal Contract for Vaccine and Biologicals. CDC Federal Contract Number: 75D30125D00198, Manufacturer: GlaxoSmithKline…

GlaxoSmithKline Financial has been awarded Texas contract HHSTX-6-0000397111, effective March 11, 2026, under the authority of Texas Government Code Section 2155.144. This award corresponds to the Centers for Disease Control and Prevention (CDC) Federal Contract Number 75D30125D00198 for vaccine and biologicals procurement. The contract encompasses the supply of Menveo-one conjugate meningococcal vaccine and associated pharmaceutical products classified under the Serums, Toxoids, and Vaccines category (NIGP Code 26980).

The deliverables under this contract include diphtheria and tetanus and whole-cell pertussis vaccine, immunomodulating drugs based on tyrosine inhibitors and kinase inhibitors, hyaluronate-based pharmaceutical compounds, tolvaptan, and thymalfasin. These products are procured by the State of Texas for public health purposes and fall within the biologicals and pharmaceutical supplies commodity classifications. Specific contract value, annual amounts, cumulative value, and detailed performance periods are not disclosed in the available contract documentation.